Bonomini 2006.
Study characteristics | ||
Methods | Study characteristics
|
|
Participants | Baseline characteristics
|
|
Interventions | Intervention group 1
Intervention group 2
Control group
|
|
Outcomes | Outcomes relevant to this review
|
|
Notes | Other information
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Study was described as randomised; method of randomisation was not reported |
Allocation concealment (selection bias) | Unclear risk | Insufficient information to permit judgement |
Blinding of participants and personnel (performance bias) | Low risk | Quote: "double‐blind placebo‐controlled" study |
Blinding of outcome assessment (detection bias) QoL | Low risk | Quote: "double‐blind placebo‐controlled" study |
Blinding of outcome assessment (detection bias) Fatigue score | Low risk | Quote: "double‐blind placebo‐controlled" study |
Incomplete outcome data (attrition bias) QoL | Unclear risk | Quote: "Thirty‐one patients dropped out, mainly due to kidney transplantation (N=13) or informed consent withdrawal (N=10)." Insufficient information to permit judgement |
Incomplete outcome data (attrition bias) Fatigue score | Unclear risk | Quote: "Thirty‐one patients dropped out, mainly due to kidney transplantation (N=13) or informed consent withdrawal (N=10)." Insufficient information to permit judgement |
Selective reporting (reporting bias) | Unclear risk | Insufficient information to permit judgement |
Other bias | High risk | Funding source: Grant/Research Support: Sigma‐Tau S.p.A.; Other: Sigma‐Tau S.p.A.; R. Camerini is an employee of Sigma‐Tau S.p.A. |